In addition, CKD-WID at doses of 1.0 and 3.0 μM under stimulation with both RANKL and MSU markedly attenuated bone resorption activity, compared with cells without CKD-WID treatment (Figure 3E). This evidence concerns the gene TNFSF11 and chronic kidney disease.